Zhitong Finance App News, Zhongguancun (000931.SZ) issued an announcement. Beijing Huasu Pharmaceutical Co., Ltd. (hereinafter referred to as Beijing Huasu), a subsidiary of the company, recently received the approval and issuance of lidocaine tincaine cream (Specification: 15g: lidocaine 1,050 mg and butcaine 1,050 mg; 30g: lidocaine 2,100 mg and dicaine 2,1002,100 mg) “Drug Clinical Trial Approval Notice”.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.